Silicon Laboratories (NASDAQ: SLAB) It was lowered by stock investigators in BidaskClub of a "sale" classification to a "strong sale" rating on a research note issued to investors this Tuesday.
Several other research companies have also recently weighed in the SLAB. Zacks Investment Invested up-to-date stock of Silicon Laboratories from a "hold" rating to a "purchase" rating and set a price target of $ 107.00 for the company in a research report on Tuesday, July 31. B. Riley increased its price target in the actions of Silicon Laboratories to $ 123.00 and gave the inventory a "buy" rating on a research report on Wednesday, July 25. Loop Capital reduced its price targets in shares of Silicon Laboratories to $ 110.00 and established a "wait" rating for the company in a research report on Thursday, July 26. Needham & Company LLC reduced its price targets in shares of Silicon Laboratories from $ 115.00 to $ 110.00 and established a "purchase" rating for the company in a research report on Friday, October 26. Finally, Barclays lowered its price target for Silicon Laboratories from $ 100.00 to $ 90.00 and established a "equal weight" rating for the company in a research report on Tuesday October 23. A stock analyst valued the stock with a sales rank, six issued a basement rating and seven issued a purchase rating for the company. The company has an average rating of "Hold" and a consensus target price of $ 105.27.
SLAB's shares traded $ 0.94 during trading on Tuesday, reaching $ 81.80. The company had a volume of trading of 136,060 shares, compared to its average volume of 269,034. The company has a ratio of debt to equities of 0.34, a current ratio of 5.44 and a quick ratio of 4.91. Silicon Laboratories has a minimum of 12 months of $ 75.89 and a maximum of 12 months of $ 110.70. The stock has a market capitalization of $ 3.64 billion, a ratio of 34.81 of PE, a price growth ratio of 2.03 and a beta of 1.60.
The Silicon Laboratories (NASDAQ: SLAB) published their figures quarterly on Wednesday, October 24. The semiconductor company reported 1.01 earnings per share in the quarter, exceeding the consensus estimate of $ 0.98 in 0.03 dollars. The silicon laboratories had a net margin of 7.45% and a return on equity of 12.48%. The company received revenues of 230.20 million dollars during the quarter, compared with the expectations of the analysts of 227.36 million dollars. During the same quarter of the previous year, the company posted $ 0.90. Revenues from Silicon Laboratories increased 15.9% annually. As a group, stock analysts expect Silicon Laboratories to publish 2.77 earnings per share for the current fiscal year.
In other news from Silicon Laboratories, SVP Alessandro Piovaccari sold 1,607 stock of the stock of the company in an operation on Wednesday, August 15. The shares were sold at an average price of $ 94.50, for a total transaction of $ 151,861.50. Following the conclusion of the sale, the Senior Vice President now has 31,074 shares in the company, valued at approximately 2,936,493 dollars. The sale was disclosed in a presentation with the Securities and Exchange Commission, which is accessible through this hyperlink. In addition, director William G. Bock sold 1,000 shares of the company's stock in an operation on Wednesday, August 15. The shares were sold at an average price of $ 94.50, for a total transaction of $ 94,500.00. After the sale, the director now has 40,751 shares of the company's stock, valued at approximately 3,850,969.50 dollars. The disclosure of this sale can be found here. Insiders sold a total of 5,416 stocks of stock of the company valued at 490,217 dollars in the last quarter. Private companies own 1.96% of the company's shares.
Several institutional investors have recently modified their holdings in the business. Laurion Capital Management LP bought a new share in the shares of Silicon Laboratories during the third quarter valued at $ 423,000. Riverhead Capital Management LLC grew 28.1% in its third quarter in its shares in Silicon Laboratories shares. Riverhead Capital Management LLC now has 4,554 shares of the shares of the semiconductor company worth $ 418,000 after buying an additional 1,000 shares during the period. Tower Research Capital LLC TRC has increased its shares in silicon laboratories shares by 283.0% in the third quarter. Tower Research Capital LLC TRC now has 2,658 stock shares of the semiconductor company worth $ 244,000 after buying another 1,964 shares during the period. Mirae Asset Global Investments Co. Ltd. It acquired a new position in shares of Silicon Laboratories in the third quarter valued at $ 2,950,000. Finally, Stevens Capital Management LP acquired a new position in shares of Silicon Laboratories in the third quarter valued at 356,000 dollars. Institutional investors own 92.37% of the stock of the company.
About the silicon laboratories
Silicon Laboratories Inc., a wireless semiconductor company, designs, develops and markets integrated mixed signal (IC) circuits in the United States, China and internationally. The company offers Internet products of things, such as the 8-bit mixed signal, the 32-bit wireless microcontrollers and the 32-bit ultra-low; wireless connectivity devices, including Gecko-on-chip wireless multi-protocol devices; real-time operating systems; sensor products that comprise magnetic sensors, optical humidity / temperature and room sensors.
Additional reading: Average daily volume of commerce: what it means in stock trading
Receive news and ratings for Silicon Laboratories Daily – Enter your email address below to receive a concise daily summary of the latest news and qualifications from analysts at Silicon Laboratories and companies related to the free email newsletter of MarketBeat.com.